Popular terms

[SEARCH]

Follow us on Twitter
twitter icon@FreshPatents

Web & Computing
Cloud Computing
Ecommerce
Search patents
Smartphone patents
Social Media patents
Video patents
Website patents
Web Server
Android patents
Copyright patents
Database patents
Programming patents
Wearable Computing
Webcam patents

Web Companies
Apple patents
Google patents
Adobe patents
Ebay patents
Oracle patents
Yahoo patents

[SEARCH]

Arm patents



      
           
This page is updated frequently with new Arm-related patent applications. Subscribe to the Arm RSS feed to automatically get the update: related Arm RSS feeds. RSS updates for this page: Arm RSS RSS


Externally serviceable it memory dimms for server/tower enclosures

Lenovo Enterprise Solutions (singapore) Pte.

Externally serviceable it memory dimms for server/tower enclosures

Actuator with dual finger grip portions

Molex

Actuator with dual finger grip portions

Actuator with dual finger grip portions

Apple

Low-travel key mechanisms using butterfly hinges


Date/App# patent app List of recent Arm-related patents
08/27/15
20150245547 
 Method and  use of organic and mineral admixtures for emi and radioisotope shielding of air filtration media and building materials, for absorption of airborne particulates and for climate change mitigation patent thumbnailMethod and use of organic and mineral admixtures for emi and radioisotope shielding of air filtration media and building materials, for absorption of airborne particulates and for climate change mitigation
The invention of high efficient multipurpose air filtration media for absorption of greenhouse gases such as co2 for climate change mitigation (lessening the severity of global warming) and absorption of airborne particulates (pm 0.5 μ-2.5 μ) and the electromagnetic and radioactive isotope shielding of building materials such as wall liners and wall coverings and reflective ceiling insulation using an absorbent organic admixture composed of a polysaccharide such as hydroxypropylcellulose, a synergistic monosaccharide such as ethoxylated methylglucoside and de-ionized water and mineral additives such as tio2, zeolites (heu & ca-a(5a)) and boehmites (curie formula) is disclosed.. .

08/27/15
20150245498 
 Externally serviceable it memory dimms for server/tower enclosures patent thumbnailExternally serviceable it memory dimms for server/tower enclosures
A method is disclosed for manufacturing an electronic component carrier. The method comprises positioning a header of a frame between opposing attachment arms extending outwardly for attaching an electronic component for seating within the frame.
Lenovo Enterprise Solutions (singapore) Pte. Ltd.


08/27/15
20150244109 
 Actuator with dual finger grip portions patent thumbnailActuator with dual finger grip portions
A low profile cable connector for use with electronic devices has a connector body with a latching member supported thereon. The latching member is mounted to the connector body so that it may be selectively moved up or down by way of an actuator.
Molex Incorporated


08/27/15
20150243457 
 Low-travel key mechanisms using butterfly hinges patent thumbnailLow-travel key mechanisms using butterfly hinges
A key mechanism including one or more butterfly hinges. Each butterfly hinge may include a double wing design operative to move between a depressed position and non-depressed position.
Apple Inc.


08/27/15
20150243268 
 Drum stand patent thumbnailDrum stand
The drum stand includes a stand main body, a drum support, and an attachment that attaches the drum support to the stand main body. The drum support is composed of a first arm and two second arms that open and close with respect to the first arm.
Hoshino Gakki Co., Ltd.


08/27/15
20150243076 
 Method of smart grading based on parameterized draft patent thumbnailMethod of smart grading based on parameterized draft
An automatic garment grading is provided. A retargeting technique is used with the mediator and the correspondence function.

08/27/15
20150243032 
 False alarm rejection for boat detection candidates patent thumbnailFalse alarm rejection for boat detection candidates
A method for rejecting false alarms in preliminary detected ship candidates includes: receiving an image including the plurality of preliminary ship candidates; computing intensity and gradient statistics from an image background around each of the preliminary ship candidates; determining a set of thresholds from the computed intensity and gradient statistics; determining an outline and an orientation for each of the preliminary ship candidates, using the computed intensity and gradient statistics; extracting a plurality of features from each of the outlines and orientations of the preliminary ship candidates, wherein the plurality of features includes intensity-based features, gradient-based features, texture-based features and shape-based features; and rejecting false alarms in the plurality of preliminary detected ship candidates using the extracted features and the determined thresholds and statistical distance classifiers.. .
Raytheon Company


08/27/15
20150242592 
 System and  a new prescription scan patent thumbnailSystem and a new prescription scan
A method and system may provide a new prescription order interface and service which allows a customer to order one or more new prescription medications in a quick and easy manner from a remote location using a computer or a mobile device. The customer provides a new paper prescription image that includes the prescription data for a pharmacy to fill the new prescription order.
Walgreen Co.


08/27/15
20150242591 
 Pharmacy automation using autonomous robot patent thumbnailPharmacy automation using autonomous robot
A pharmacy automation system having a robot having a hardware device and a software for internal mapping to perform simultaneous localization and mapping (slam) is disclosed herein. The robot is configured to use the slam technique to carry out at least the following different interactions: the robot communicates autonomously with a physician or an assistant directly or via an intermediary; the robot interacts with an inventory of goods and browses the inventory of goods to determine if a prescribed medication is available in the pharmacy; if the prescribed medication is available in the pharmacy, the robot interacts with a medication dispenser, using the internal mapping to fill a container with the prescribed medication, and store the container; when a patient or a proxy arrives to pick up the prescribed medication, the robot checks and approves an identification of the patient or the proxy; and when the patient or proxy presents a prescription containing the prescribed medication, the robot retrieves the container with the prescribed medication and hands the container with the prescribed medication over to the patient or proxy..

08/27/15
20150242549 
 Method of constructing surface roughness change model for wind farm micro-sitting patent thumbnailMethod of constructing surface roughness change model for wind farm micro-sitting
A method of constructing roughness change model for wind farm micro-sitting includes following steps. A roughness change model is established.
Wind Power Technology Center Of Gansu Electric Power Company


08/27/15
20150242182 

Voice augmentation for industrial operator consoles


A method includes receiving first audio data from an operator associated with an industrial control and automation system. The method also includes identifying one or more recognition events associated with the first audio data, where each recognition event is associated with at least a portion of the first audio data that has been recognized using at least one grammar.
Honeywell International Inc.


08/27/15
20150242171 

Pharmacy printer system and method


A computer network system and method for printing accompanying information and prescription labels in pharmacies, comprises: a central cs; a pms; a data transmission network through which said pms and said central cs can communicate; wherein said pms includes an i/o terminal, a scanner, and a first printer; wherein said pms includes a pms so and a catalina so; said pms so is configured to receive and store prescription information for a prescription, and to associate a prescription identification with said prescription; said catalina so is configure to select accompanying information for said prescription, to format and save said accompanying information in an accompanying information print file; and said pms is configured to print a prescription label for said prescription and said accompanying information print file.. .
Inventiv Health, Inc.


08/27/15
20150241175 

Accessory mounting system for firearms


A firearm having a mounting surface which can include a recess formed on a slide of a pistol. The recess includes mounting posts and a plurality of sights include matching openings and fasteners so that mounting platforms of the plurality of sights can be mounted in the recess in a fixed orientation.
Zev Technologies, Inc.


08/27/15
20150241160 

Handguard with integrated pod and firearm


Firearms and handguards for firearms having three pivotably attached pods wherein a first pod is deployable as a monopod and second and third pods are deployable together as a bipod, or having at least one pivotable pod having at least one hinge pin, at least one locking pin, and at least one return spring that biases the at least one locking pin. In some embodiments, a return spring, a slide spindle, a locking spindle, or a combination thereof, push two locking pins, for example, into opposite detents when the pod is pivoted into a deployed position, and the pod can be released by moving a slide button and secured in a stowed position with a catch.
S. I. Defense, Inc.


08/27/15
20150240883 

Clutch assembly having a clamp spring


A clutch assembly for transferring torque between a flywheel of an engine and a transmission, the clutch assembly comprising a housing, a pressure plate fixedly secured to the housing, the pressure plate operatively arranged to cause a friction clutch disc to rotate the flywheel, wherein the pressure plate is arranged for rotation about an axis of rotation, wherein the pressure plate is axially movable relative to the axis of rotation, and including actuation means for engaging and disengaging the clutch, an adjustment means operatively arranged to adjust travel of the pressure plate and the friction clutch disc, and a plurality of lever arms, operatively arranged to amplify force within the clutch assembly, the adjustment means comprising a clamp spring having a first end operatively arranged to prevent an uncontrolled movement of the adjustment means and a second end operatively arranged to center the adjustment means within the clutch assembly.. .
Schaeffler Technologies Ag & Co. Kg


08/27/15
20150240847 

Self gripping clip apparatus


The present invention relates to a clip apparatus adapted to receive and engage a sheet of material such as paper, cardboard, plastic, film, posters or any other material that comes in sheet form. The invention includes a clip assembly having a first arm and a second arm and a plurality of fins that are disposed on an inner surface of the arms that are adapted to receive and engage the sheet of material inserted between the arms.
Roylco, Inc.


08/27/15
20150240784 

System and automatic generation control in wind farms


A system for automatic generation control in a wind farm is provided. The system includes a wind farm controller for controlling the plurality of energy storage elements.
General Electric Company


08/27/15
20150240671 

Variable valve device for internal combustion engine


Provided is a variable valve device for an internal combustion engine, capable of improving engine characteristics by increasing the maximum valve lift of an intake valve to a large valve lift while preventing excessive lost motion operation of lost motion mechanisms. The variable valve device includes intake- and exhaust-side swing arms that pivot to open and close intake valves (3a, 3b) and exhaust valves (61a, 61b) in two cylinders #1, #2, intake- and exhaust-side hydraulic lash adjusters (10a, 10b, 65a, 65b) that serve as pivot points of the respective swing arms, a variable valve system that continuously varies valve lift characteristics of the intake valves and lost motion mechanisms (11) that stop opening and closing of the intake exhaust valves by lost motion of the intake- and exhaust-side hydraulic lash adjusters on the cylinder #1.
Hitachi Automotive Systems, Ltd.


08/27/15
20150240028 

Biodegradable polymer compound


The purpose of the present invention is to provide a biodegradable polymer compound that is pliable and displays the same decomposition behavior as linear lactic acid-ε-caprolactone copolymer. The problem is solved by a branched polymer (particularly, a star-shaped polymer) having at least three arms formed from lactic acid-ε-caprolactone copolymer and a weight-average molecular weight of at least 150,000..
Gunze Limited


08/27/15
20150239926 

Asymmetric ionizable cationic lipid for rna delivery


Or a pharmaceutically acceptable salt thereof.. .

08/27/15
20150239922 

Water-soluble o-carbonyl phosphoramidate prodrugs for therapeutic administration


Or pharmaceutically acceptable salts thereof that are therapeutic or antibacterial agents, pharmaceutical compositions containing them, methods for their use, and reagents and methods for preparing these compounds.. .

08/27/15
20150239921 

Phosphonate compounds for treatment of complement mediated disorders


Compounds, methods of use, and processes for making inhibitors of complement factor d comprising formula i, or a pharmaceutically acceptable salt or composition thereof wherein r12 or r13 on the a group is a phosphonate (r32) are provided. The inhibitors described herein target factor d and inhibit or regulate the complement cascade at an early and essential point in the alternative complement pathway, and reduce factor d's ability to modulate the classical and lectin complement pathways.
Achillion Pharmaceuticals, Inc.


08/27/15
20150239920 

Ether compounds for treatment of complement mediated disorders


Compounds, methods of use, and processes for making inhibitors of complement factor d comprising formula i, or a pharmaceutically acceptable salt or composition thereof wherein r12 or r13 on the a group is an ether (r32) are provided. The inhibitors described herein target factor d and inhibit or regulate the complement cascade at an early and essential point in the alternative complement pathway, and reduce factor d's ability to modulate the classical and lectin complement pathways.
Achillion Pharmaceuticals, Inc.


08/27/15
20150239919 

Carbamate, ester, and ketone compounds for treatment of complement mediated disorders


Compounds, methods of use, and processes for making inhibitors of complement factor d comprising formula i, or a pharmaceutically acceptable salt or composition thereof, wherein r12 or r13 on the a group is a carbamate, ester, or ketone substituent (r32) are provided. The inhibitors described herein target factor d and inhibit or regulate the complement cascade at an early and essential point in the alternative complement pathway, and reduce factor d's ability to modulate the classical and lectin complement pathways.
Achillion Pharmaceuticals, Inc.


08/27/15
20150239908 

Alkyl-substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds


Compounds, tautomers and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of formula i, as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed..
Pfizer Inc.


08/27/15
20150239905 

Imidazopyridine compounds


The invention relates to compounds of formula (i): and their pharmaceutically acceptable salts and solvates, which are inhibitors of ssao activity. The invention further relates to pharmaceutical compositions comprising these compounds and to the use of these compounds for the treatment or prevention of medical conditions wherein inhibition of ssao activity is beneficial, such as inflammatory diseases and immune disorders..
Proximagen Limited


08/27/15
20150239900 

Inhibitors of kras g12c


Or a pharmaceutically acceptable salt, tautomer, prodrug or stereoisomer thereof, wherein r1, r2a, r3a, r3b, r4a, r4b, g1, g2, l1, l2, m1, m2, a, b, w, x, y, z and e are as defined herein. Methods associated with preparation and use of such compounds, pharmaceutical compositions comprising such compounds and methods to modulate the activity of g12c mutant kras protein for treatment of disorders, such as cancer, are also provided..

08/27/15
20150239896 

Deuterated derivatives of ruxolitinib


Or a pharmaceutically acceptable salt thereof; pharmaceutical compositions comprising the compound; and methods of treating the indications disclosed herein.. .

08/27/15
20150239895 

Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders


Compounds, methods of use, and processes for making inhibitors of complement factor d comprising formula i, or a pharmaceutically acceptable salt or composition thereof wherein r12 or r13 on the a group is an aryl, heteroaryl or heterocycle (r32) are provided. The inhibitors described herein target factor d and inhibit or regulate the complement cascade at an early and essential point in the alternative complement pathway, and reduce factor d's ability to modulate the classical and lectin complement pathways.
Achillion Pharmaceuticals, Inc.


08/27/15
20150239894 

Amino compounds for treatment of complement mediated disorders


Compounds, methods of use, and processes for making inhibitors of complement factor d comprising formula i, or a pharmaceutically acceptable salt or composition thereof, wherein r12 or r13 on the a group is an amino substituent (r32) are provided. The inhibitors described herein target factor d and inhibit or regulate the complement cascade at an early and essential point in the alternative complement pathway, and reduce factor d's ability to modulate the classical and lectin complement pathways.
Achillion Pharmaceuticals, Inc.


08/27/15
20150239893 

Amide compounds for treatment of complement mediated disorders


Compounds, methods of use, and processes for making inhibitors of complement factor d comprising formula i, or a pharmaceutically acceptable salt or composition thereof, wherein r12 or r13 on the a group is an amide substituent (r32) are provided. The inhibitors described herein target factor d and inhibit or regulate the complement cascade at an early and essential point in the alternative complement pathway, and reduce factor d's ability to modulate the classical and lectin complement pathways.
Achillion Pharmaceuticals, Inc.


08/27/15
20150239888 

Modulators of toll-like receptor 7


Or a pharmaceutically acceptable salt, solvate, and/or ester thereof, compositions containing such compounds, therapeutic methods that include the administration of such compounds, and therapeutic methods that include the administration of such compounds with at least one additional active agent.. .

08/27/15
20150239885 

Pi3k and/or mtor inhibitor


The present invention relates to a compound of formula (i), or a pharmaceutically acceptable salt, a stereoisomer or a solvate thereof, wherein r1, r2, r3, r4, x, y, a and b are as defined in the specification. The present invention further relates to a method for preparing these compounds, a pharmaceutical composition containing these compounds, and a use of these compounds in manufacture of a medicament for treating and/or preventing proliferative diseases..
Xuanzhu Pharma Co., Ltd.


08/27/15
20150239873 

Substituted carbamate compounds


And pharmaceutically acceptable salts thereof. In addition, the present invention relates to methods of manufacturing and using the compounds of formula (i) as well as pharmaceutical compositions containing such compounds.

08/27/15
20150239868 

Alkyne compounds for treatment of complement mediated disorders


Compounds, methods of use, and processes for making inhibitors of complement factor d comprising formula i, or a pharmaceutically acceptable salt or composition thereof, wherein r12 or r13 on the a group is an alkyne (r32) are provided. The inhibitors described herein target factor d and inhibit or regulate the complement cascade at an early and essential point in the alternative complement pathway, and reduce factor d's ability to modulate the classical and lectin complement pathways.
Achillion Pharmaceuticals, Inc.


08/27/15
20150239864 

3h-1,2-dithiocyclopentene-3-thioketone compounds and application thereof


The present invention relates to the field of medicaments, and in particular relates to 3h-1,2-dithiocyclopentene-3-thione compounds and application thereof. 3h-1,2-dithiocyclopentene-3-thione compounds disclosed by the invention have new structures shown in formula i or formula ii.
Soochow University


08/27/15
20150239862 

Process for the preparation of vilanterol and intermediates thereof


An improved process for the preparation of vilanterol and pharmaceutically acceptable salts thereof is disclosed. More specifically the improved process for preparing intermediates for the preparation of vilanterol is disclosed..
Perrigo Api Ltd.


08/27/15
20150239857 

(thio)morpholine derivatives as s1p modulators


The present invention relates to (thio)morpholine derivatives of the formula (i), wherein r1 is selected from cyano, (2-4c)alkynyl, (1-4c)alkyl, (3-6c)cycloalkyl, (4-6c)cycloalkenyl, (6-8c)bicycloalkyl, (8-10c)bicyclic group, each optionally substituted with (1-4c)alkyl, phenyl, biphenyl, naphthyl, each optionally substituted with one or more substituents independently selected from halogen, (1-4c)alkyl optionally substituted with one or more fluoro atoms, (2-4c)alkynyl, (1-4c)alkoxy optionally substituted with one or more fluoro atoms, amino, di(1-4c)alkylamino, —so2-(1-4c)alkyl, —co-(1-4c)alkyl, —co—o-(1-4c)alkyl, —nh—co-(1-4c)alkyl and (3-6c)cycloalkyl, phenyl substituted with phenoxy, benzyl, benzyloxy, phenylethyl or monocyclic heterocycle, each optionally substituted with (1-4c)alkyl, monocyclic heterocycle optionally substituted with halogen, (1-4c)alkyl or with phenyl optionally substituted with (1-4c)alkyl, and bicyclic heterocycle optionally substituted with (1-4c)alkyl; a is selected from —co—o—, —o—co—, —nh—co—, —co—nh, —c═c—, —cch3—o— and the linking group —y—(ch2)u—x— wherein y is attached to r1 and selected from a bond, —o—, —s—, —so—, —so2—, —ch2—o—, —co—, —o—co—, —co—o—, —co—nh—, —nh—co—, —c═c— and —c≡c—; n is an integer from 1 to 10; and x is attached to the phenylene/pyridyl group and selected from a bond, —o—, —s—, —so—, —so2—, —nh, —co—, —c═c— and —c≡c—; ring structure b optionally contains one nitrogen atom; r2 is h, (1-4c)alkyl optionally substituted with one or more fluoro atoms, (1-4c)alkoxy optionally substituted with one or more fluoro atoms, or halogen; and r3 is (1-4c)alkylene-r5 wherein the alkylene group may be substituted with (ch2)2 to form a cyclopropyl moiety or one or two halogen atoms, or r3 is (3-6c)cycloalkylene-r5 or —co—ch2—r5, wherein r5 is —oh, —po3h2, —opo3h2, —cooh, —coo(1-4c)alkyl or tetrazol-5-yl; r4 is h or (1-4c)alkyl; r6 is one or more substituents independently selected from h, (1-4c)alkyl or oxo; w is —o—, —s—, —so— or —so2—; or a pharmaceutically acceptable salt, a solvate or hydrate thereof; with the proviso that the derivative of formula (i) is not 2-(4-ethylphenyl)-4-morpholinoethanol or 4-[4-(2-hydroxyethyl)-2-morpholinyl]benzeneacetonitrile or a pharmaceutically acceptable salt, a solvate or hydrate thereof. The compounds of the invention have affinity to s1p receptors and may be used in the treatment, alleviation or prevention of s1p receptor mediated diseases and conditions..
Abbvie Bahamas Limited


08/27/15
20150239842 

Benzamide and heterobenzamide compounds


This invention relates to compounds of general formula (i), in which r1, r2, r6, u, v, w, x, y and z are as defined herein, and the pharmaceutically acceptable salts thereof, pharmaceutical compositions containing such compounds and salts, and to methods of using such compounds, salts and compositions.. .
Pfizer Inc.


08/27/15
20150239838 

Compounds for treatment of complement mediated disorders


Compounds, methods of use, and processes for making inhibitors of complement factor d comprising formula i, or a pharmaceutically acceptable salt or composition thereof are provided. The inhibitors described herein target factor d and inhibit or regulate the complement cascade at an early and essential point in the alternative complement pathway, and reduce factor d's ability to modulate the classical and lectin complement pathways.
Achillion Pharmaceuticals, Inc.


08/27/15
20150239837 

Factor d inhibitors useful for treating inflammatory disorders


Compounds, methods of use, and processes for making inhibitors of complement factor d comprising formula i, or a pharmaceutically acceptable salt or composition thereof are provided. The inhibitors described herein target factor d and inhibit or regulate the complement cascade at an early and essential point in the alternative complement pathway, and reduce factor d's ability to modulate the classical and lectin complement pathways.
Achillion Pharmaceuticals, Inc.


08/27/15
20150239834 

Symmetric ionizable cationic lipid for rna delivery


Consists of a compound in which r1 consists of a branched alkyl with 12 to 20 carbons; r2 consists of a linear alkyl with 5 to 10 carbons or a branched alkyl with 12 to 20 carbons; l1 and l2 each consists of a bond or a linear alkyl having 1 to 3 carbon atoms; x consists of s or o; l3 consists of a bond or a lower alkyl; r3 consists of a lower alkyl; and r4 and r5 are the same or different, each consisting of a lower alkyl. The compound of formulas ii, iii and iv may comprise a pharmaceutically acceptable salt thereof..

08/27/15
20150239716 

Method for signaling the danger of a crane tipping


The invention relates to a method for signaling the danger of a crane tipping, comprising at least three alarm systems for signaling tipping warnings using a respective safety programme. At least one measurement value is obtained from the crane, at least two alarm systems for signaling the tipping warning are selected in accordance with the at least one measurement value and if a warning of tipping is signaled by at least two of the at least two selected alarm signals, a tipping warning is signalled..
Palfinger Ag


08/27/15
20150239713 

Hydraulic grapple


The invention relates to a grapple assembly in which a single actuator is used to operate the arms of the grapple but each arm is able to at least partly open and/or close independently of the other arms. A grapple assembly comprises an elongate core comprising a linear actuator; means for connecting the first end of the elongate core to a grapple hoist; a plurality of grapple arms connected to the second end of the elongate core by a pivotal connection oriented substantially perpendicularly to the elongate core; a plurality of elastically deformable connectors, each connector having coupled directly or indirectly to a connection region of the elongate core and coupled to one of the grapple arms at a point on the respective grapple arm spaced apart from the pivotal connection of the respective grapple arm to the elongate core, wherein the linear actuator is able to be actuated to move the connection region of the elongate core relative to the second end of the elongate core to open and/or close the plurality of grapple arms, and wherein the elastically deformable connectors permit each grapple arm to at least partly open and/or close independently of the other grapple arms upon exertion of an external force on the respective grapple arm..
A Ward Attachments Limited


08/27/15
20150239560 

Lightweight conveyor roller


A roller made lighter through the use of lightening elements. The inventive roller, with its lightening element(s), is lighter yet maintains its overall dimensions, is strong and durable enough to withstand the rigors of the transportation industry and/or is cost effective to produce and maintain.
Advanced Aircraft Roller Systems, Inc.


08/27/15
20150239375 

Vertically adjustable armrest assembly for a vehicle interior component


An armrest assembly includes a pivot joint positioned at a first longitudinal end of the armrest assembly. The pivot joint is configured to rotatably couple the armrest assembly to a housing of a vehicle interior component.
Johnson Controls Technology Company


08/27/15
20150239353 

Method for controlling the charging of a battery of an electric vehicle in a non-contact charging system


A method for controlling charging of a battery of an electric drive motor vehicle or a hybrid motor vehicle, in a non-contact charging system wherein a power generator including a direct current source followed by an inverter feeds a load including an inductor arranged in series with the inverter, the method including: controlling the inverter at a working frequency slaved to a load resonance frequency by transmission of first and second pulse-width modulation command signals respectively to first and second switching arms of the inverter; and performing a closed-loop regulation on an intensity of a supply current of the inverter, a supply current set value being defined according to a maximum current that can be supplied by the direct current source.. .
Renault S.a.s.


08/27/15
20150239284 

Novel barnstar assembly


A barnstar includes a plurality of star arms, each of the plurality of star arms formed of first and second facets, each first and second facet presenting an exterior surface, each of the first and second facets being triangular and having a flush periphery edge, an inclined arm length periphery and an inclined assembly edge, with each first and second facet of a star arm being joined at the inclined arm length periphery, each inclined assembly edge providing a interior mounting flange having at least one aperture therein, wherein each interior mounting flange of each of the first facets lies flush against an interior mounting flange of a neighboring one of the second facets such that the apertures therein are aligned and have fasteners therethrough that secure neighboring facets together, with the fasteners being hidden from view at the exterior surface of each first and second facet. .

08/27/15
20150239133 

Gravity-counterbalanced robot arm


An arm assembly for use in a robot to provide gravity counterbalancing of the robot arms. The arm assembly includes an arm and a drive assembly.
Disney Enterprises, Inc.


08/27/15
20150239119 

Magnetic mount for power tool


A magnetic mount for a power tool to secure the power tool to a ferrous surface includes a substantially u-shaped bracket including a spaced apart pair of mounting arms each having a base end and an opposite distal end, a rigid cross-member joining the pair of mounting arms at the base ends, a mounting head on each distal end of the pair of mounting arms, at least one magnet mounted on the cross-member, wherein the pair of mounting arms are disposed in a first direction from the cross member and the magnet is disposed in a second direction substantially opposite to the first direction, from the cross member, and wherein the mounting heads are adapted for mounting to at least one side of the power tool.. .

08/27/15
20150239018 

Movable rack assembly with corner spray nozzles


A movable rack assembly for a washer having a generally rectangular frame. The frame includes a central hub connectable to a fluid source.
Steris Inc.


08/27/15
20150239000 

Maintenance device for fasteners


There is provided in a preferred embodiment of the present invention a maintenance device having a lubricant reservoir attached to the upper end of a fixed body, and a dynamic body that is slidably engaged and disposed within the fixed body at the lower end thereof. Attached to the base of dynamic body is a trio of cleaning arms.

08/27/15
20150238848 

Card shuffler


Systems, apparatuses and methods are described for shuffling a deck, group, stack or pile of cards. The cards are placed into a shuffler.
Digideal Corporation


08/27/15
20150238805 

Exercise bike


An exercise bike includes a frame, a driving member, two sun gears, two swing arms, two planet gears, and two cranks. The driving member is assembled to the frame and has a shaft extending from two sides of the frame.
Ventek Fitness Corporation


08/27/15
20150238802 

Performance training tool


Disclosed herein are tether lines comprising a handle; a grapple, comprising a body, two stationary arms, and a swing arm configured to rotate around a pivot point in between the stationary arms; and a cable connecting the handle with the grapple. Also disclosed are methods of temporarily restraining an athlete, the methods comprising providing a tether line comprising a handle; a grapple, comprising a body, two stationary arms, and a swing arm configured to rotate around a pivot point in between the stationary arms; and a cable connecting the handle with the grapple; connecting the grapple to the athlete; and applying pressure to a release trigger on the handle, thereby causing the swing arm to swing open, thereby disconnecting the athlete from the grapple..
Canyon Hard Goods Llc


08/27/15
20150238711 

Method and humidification and warming of air


A gas apparatus for use in a medical procedure may include a housing, a heater, a port, and a dispensing device. The housing defines a chamber having a gas inlet and a gas outlet.
Northgate Technologies Inc.


08/27/15
20150238610 

Excipients for use in adeno-associated virus pharmaceutical formulations, and pharmaceutical formulations made therewith


Stable pharmaceutical compositions comprising recombinant adeno-associated virus (aav) virions are described. The compositions provide protection against loss of recombinant aav vector genomes and transduceability under conditions such as exposure to cycles of freezing and thawing and storage in glass or polypropylene vials.
Genzyme Corporation


08/27/15
20150238607 

Pharmaceutical preparation comprising aminopyrazole derivative


The pharmaceutical formulations according to the present invention include an alkyl sulfate salt and a compound represented by general formula (i) below (where r1 to r4 are as defined in the specification) or tautomers thereof, or pharmaceutically acceptable salts thereof.. .
Chugai Seiyaku Kabushiki Kaisha


08/27/15
20150238570 

Therapeutic agent for hyperthermia


An object of the present invention is to provide a hypothermic agent for an animal, a therapeutic agent for hyperthermia in an animal, etc. The present invention provides a hypothermic agent for an animal, a therapeutic agent for hyperthermia in an animal, etc., the agents etc.
National Cerebral And Cardiovascular Center


08/27/15
20150238568 

Exendins to lower cholesterol and triglycerides


Provided herein are pharmaceutical formulations containing exendins, exendin agonists, or exendin analog agonists that are administered at therapeutic plasma concentration levels over a sustained period of time to lower total cholesterol levels; to lower ldl-cholesterol levels; to lower triglyceride levels; to treat dyslipidemia; to treat and slow the progression of atherosclerosis; and to treat, prevent, and reduce the risk of heart attacks and strokes in patients. In the pharmaceutical formulations and methods of the invention, the exendin may be exendin-4, an exendin-4 agonist, or an exendin-4 analog agonist.
Astrazeneca Pharmaceuticals Lp


08/27/15
20150238557 

Method of treatment or prophylaxis of infections of the eye


A microbial infection in an eye of a subject is treated or prevented by topically administering to the eye an effective amount of a macromolecule or a pharmaceutically acceptable salt thereof that includes a dendrimer of 1 to 8 generations with one or more sulfonic acid- or sulfonate-containing moieties attached to one or more surface groups of the outermost generation of the dendrimer. Compositions containing the macromolecule or salt are useful in these methods..
Starpharma Pty Limited


08/27/15
20150238528 

Formulations involving solvent/detergent-treated plasma (s/d plasma) and uses thereof


The invention concerns pharmaceutical formulations comprising solvent/detergent (s/d)-treated plasma and a glycosaminoglycan such as hyaluronic acid, and their use for treating diseases, particularly musculoskeletal diseases.. .
Enrico Bastianelli S.p.r.l.


08/27/15
20150238510 

Stable injectable composition containing diclofenac and thiocolchicoside


The invention relates to a stable injectable aqueous solution containing diclofenac and thiocolchicoside, or pharmaceutically acceptable salts thereof, and the use thereof in the treatment of painful and inflammatory rheumatic or traumatic conditions of the joints, muscles, tendons and ligaments.. .
Epifarma S.r.l.


08/27/15
20150238503 

Low dose noribogaine for treating nicotine addiction and preventing relapse of nicotine use


This invention provides methods and compositions for treating nicotine addiction or treating or preventing nicotine cravings in a subject. The method comprises administering to the patient in need thereof a therapeutically effective amount of noribogaine, noribogaine derivative, or a pharmaceutically acceptable salt thereof..
Demerx, Inc.


08/27/15
20150238502 

Compositions and methods for treating stroke


Provided herein is a method of treating a subject believed to have suffered a stroke. This method comprises administering to the subject therapeutically effective amount of a composition comprising conivaptan or an active derivative, stereoisomer, pro-drug, or pharmaceutically acceptable salt thereof..
University Of South Florida


08/27/15
20150238501 

Compounds and methods for antiviral treatment


Compounds and pharmaceutically acceptable salts and esters and compositions thereof, for treating viral infections are provided. The compounds and compositions are useful for treating pneumovirinae virus infections.
Gilead Sciences, Inc.


08/27/15
20150238500 

Pyrrole antifungal agents


The invention provides compounds of formula (i), and pharmaceutically and agriculturally acceptable salts thereof; wherein: r1, r2, r3, r4, r5, r6, a1, l1 and n are as defined herein. These compounds and their pharmaceutically acceptable salts are useful in prevention or treatment of a fungal disease.
F2g Ltd


08/27/15
20150238493 

Medicament for treating peripheral neuropathies


The invention provides a method for treatment of the diseases in a human by identifying the human as one suffering from a herpes simplex virus (hsv), and then administering to the human the compound anti-hsv agent or a pharmaceutically acceptable salt thereof. The diseases include dermatosis and non-dermatosis, wherein the dermatosis include acnes, impetigo, pyoderma gangrenosum, chilblains and psoriasiform, asteatotic dermatitis, ichthyosis, lichen simplex chronicus (neurodermatitis, prurigo), seborrhoeic dermatitis, rosacea, perioral dermatitis, epidermal cyst, wound ulcer, discoid lupus erythematosus, vitiligo, alopecia, diagnostic criteria of some autoimmune diseases such as systemic lupus erythematosus or diabetic skin complications, wherein the non-dermatosis include glomerulonephritis, arthritis, crohn's disease, ulcerative colitis, myelodysplasia, multiple myeloma, demyelinating disease, parkinson's disease, anemia, cytopenia those among the diagnostic criteria..

08/27/15
20150238489 

Heterocyclyl carboxamides for treating viral diseases


Methods, uses, medicaments, and unit doses for treating viral diseases are described herein. The methods, uses, medicaments, and unit doses include (a) substituted piperidine and piperazine carboxamides, or a pharmaceutically acceptable salt thereof and (b) one or more pharmaceutically acceptable carriers, excipients or diluents, or combinations thereof.
Novadrug, Llc


08/27/15
20150238486 

Novel uses


This invention relates to the new use of the compound (i) or pharmaceutically acceptable salts thereof and pharmaceutical compositions containing it for the treatment of pruritus and to combinations for such a use.. .
Nerre Therapeutics Limited


08/27/15
20150238485 

Oxime-substituted quinoxaline-type piperidine compounds as orl-1 modulators


And the pharmaceutically acceptable salts and solvates thereof, wherein r1, r2, r3, r4, r20, r21, q, y1, z, a, b, and a are as defined herein; compositions comprising an effective amount of an oxime-substituted quinoxaline-type piperidine compound, and methods to treat or prevent a condition, such as pain, comprising administering to an animal in need thereof an effective amount of an oxime-substituted quinoxaline-type piperidine compound.. .

08/27/15
20150238481 

Pharmaceutical formulation containing gelling agent


Disclosed in certain embodiments is a controlled release oral dosage form comprising a therapeutically effective amount of a drug susceptible to abuse together with one or more pharmaceutically acceptable excipients; the dosage form further including a gelling agent in an effective amount to impart a viscosity unsuitable for administration selected from the group consisting of parenteral and nasal administration to a solubilized mixture formed when the dosage form is crushed and mixed with from about 0.5 to about 10 ml of an aqueous liquid; the dosage form providing a therapeutic effect for at least about 12 hours when orally administered to a human patient.. .
The P.f. Laboratories


08/27/15
20150238479 

Crenolanib for treating flt3 mutated proliferative disorders


The present invention relates to the use of crenolanib, in a pharmaceutically acceptable salt form for the treatment of flt3 mutated proliferative disorders driven by constitutively activated mutant flt3, and to a method of treatment of warm-blooded animals, preferably humans, in which a therapeutically effective dose of crenolanib is administered to an animal suffering from said disease or condition:. .
Arog Pharmaceuticals, Llc


08/27/15
20150238477 

Method of treating lung adenocarcinoma


Or a pharmaceutically acceptable salt thereof.. .

08/27/15
20150238471 

6-aminopyridine-3-ol derivatives or pharmaceutically acceptable salts thereof, and pharmaceutical composition containing same as active ingredients for preventing or treating diseases caused by angiogenesis


A method or composition including 6-aminopyridin-3-ol derivatives or pharmaceutically acceptable salts thereof for treating a disease caused by angiogenesis, the 6-aminopyridin-3-ol derivatives represented by formula 1 or the pharmaceutically acceptable salts thereof have excellent neoangiogenesis inhibition effects in the chorioallantoic membrane model, and are suitable for use as a drug for the treatment of disease caused by angiogenesis.. .

08/27/15
20150238457 

Semi-solid compositions and pharmaceutical products


This invention relates to semi-solid compositions and semi-solid pharmaceutical products for use in the photodynamic treatment (pdt) of cancer, pre-cancerous conditions and non-cancerous conditions in the female reproductive system, the anus and the penis, preferably for use in pdt of endometrial, cervical, vulvar, vaginal, anal and penile dysplasia and hpv infections of the uterus, cervix, the vulva, the vagina, the anus and the penis. The semi-solid compositions and pharmaceutical products comprise an active ingredient which is 5-aminolevulinic acid (5-ala) or a precursor or derivative of 5-ala or pharmaceutically acceptable salts thereof.
Photocure Asa


08/27/15
20150238451 

Pharmaceutical compositions of diclofenac or salts thereof


The present invention refers to an improved pharmaceutical composition of diclofenac or pharmaceutically acceptable salt and pharmaceutically acceptable excipients wherein the composition is substantially free of solubilizing agents. By judicially using pharmaceutical excipients other than solubilizing agent, pharmaceutical composition of diclofenac or its salts with rapid and uniform gastrointestinal absorption of diclofenac can be achieved.
Wockhardt Limited


08/27/15
20150238449 

Benzenetricarboxylic acid and methods of use


Methods of treating or preventing cancer and/or a neurodegenerative disorder in a subject are provided. The methods comprise administering to a subject a therapeutically effective amount of 1,2,3-benzenetricarboxylic acid or a hydrate or pharmaceutically acceptable salt thereof..
Georgetown University


08/27/15
20150238445 

Composition using metformin for preventing or treating immune diseases including lupus


The present invention relates to a composition for preventing or treating immune diseases through the suppression of b cell activity induced by metformin. More particularly, the present invention relates to a composition comprising a metformin compound or a pharmaceutically acceptable salt thereof as an active ingredient for preventing or treating immune diseases, wherein the composition is characterized by suppression or reduction of b cell activity which is a cause of disease.
Catholic University Industry Academic Cooperation Foundation


08/27/15
20150238430 

Pharmaceutical composition


A pharmaceutical formulation comprising at least one omega-3 polyunsaturated fatty acid in free acid form or a pharmacologically acceptable derivative thereof is contained in a soft gelatin capsule characterised in that the capsule comprises gelatin extracted by an extraction process comprising acid pre-treatment of a collagen source. One advantage of the present invention over a soft gelatin capsule containing the same formulation but comprising gelatin extracted by an extraction process comprising alkali pre-treatment of the collagen source is that the present invention does not harden significantly over time and thus has a longer shelf life..
Chrysalis Pharma Ag


08/27/15
20150238420 

Naloxone mono preparation and multilayer tablet


The present invention relates to a solid oral pharmaceutical composition comprising naloxone, or a pharmaceutically acceptable salt thereof, as an active substance, wherein the composition releases the active substance in a prolonged manner. In order to provide a composition that is suitable for an administration period of at least twelve-hours for the treatment of opioid-induced constipation, it is proposed that the composition should have an in vitro release rate of the active substance measured using the paddle stirrer method according to ph.

08/27/15
20150238418 

Controlled release hydrocodone formulations


A solid oral controlled-release dosage form of hydrocodone is disclosed, the dosage form comprising an analgesically effective amount of hydrocodone or a pharmaceutically acceptable salt thereof, and controlled release material.. .
Purdue Pharma L.p.


08/27/15
20150238382 

Robot for walking rehabilitation therapy of stroke patient


A robot for rehabilitation therapy includes a robot body and a walker. The robot body includes a fixing band for supporting a waist of a patient, pelvic joint shafts rotatably connected to the fixing band, first arms extending downward from the pelvic joint shafts, first connecting joint shafts connected to the first arm, second arms extending downward from the first connecting joint shafts, second connecting joint shafts rotatably connected to the second arms, extension pieces extending downward from the second connecting joint shafts, and footboards rotatably connected to the extension pieces by ankle joint shafts.
Korea Institute Of Industrial Technology


08/27/15
20150238353 

Thermal therapy apparel


The present invention is a two-layer garment adapted to receive one or more body parts to provide a user with compression and thermal therapy. The two layers comprise of an inner base layer having a compression fit and an outer mesh layer.
Snapbac, Llc


08/27/15
20150238313 

Devices, delivering a prosthetic mitral valve and anchoring device


Prosthetic mitral heart valves and anchors for use with such valves are provided that allow for an improved implantation procedure. In various embodiments, a helical anchoring device is formed as a coiled or twisted anchor that includes one or more turns that twist or curve around a central axis.
Mitral Valve Technologies, Sarl


08/27/15
20150238251 

Systems and methods for treating tissue with radiofrequency energy


A system for controlling operation of a radiofrequency treatment device to apply radiofrequency energy to tissue to treat tissue to create lesions without ablating the tissue. The system includes a first treatment device having a plurality of electrodes.
Mederi Therapeutics, Inc.


08/27/15
20150238247 

Systems and methods for treating tissue with radiofrequency energy


A system for controlling operation of a radiofrequency treatment device to apply radiofrequency energy to tissue to treat tissue to create lesions without ablating the tissue. The system includes a device having flexible outer tube, an expandable basket having a plurality of arms movable from a collapsed position to an expanded position, a plurality of electrodes movable from a retracted position to an extended position to extend through the openings in the arms, and an advancer slidably disposed within the outer tube to move the electrodes.
Mederi Therapeutics, Inc.


08/27/15
20150238235 

Polyaxial pedicle screw locking and derotation instrument


A pedicle screw locking and derotation instrument, comprising: an elongate actuation mechanism, wherein the elongate actuation mechanism comprises a pair of elongate arms that are pivotably hinged to one another and comprise a pair of handle portions; and a pair of clamp members coupled to the elongate actuation mechanism and deployed by actuation of the elongate actuation mechanism; wherein each of the pair of clamp members comprises a retention portion configured to selectively and securely engage a threaded shaft of a pedicle screw and a portion configured to selectively and securely engage a head body of the pedicle screw, thereby holding the threaded shaft and the head body in rigid alignment; wherein each of the pair of clamp members comprises a retention portion that is configured to be selectively disposed beneath the head body of the pedicle screw and about the threaded shaft of the pedicle screw.. .

08/27/15
20150238159 

System and performing bi-plane tomographic acquisitions


A method includes, in a bi-plane interventional imaging system, moving a first c-arm supporting a first x-ray source and a first x-ray detector about first and second axes while obtaining a plurality of first x-ray attenuation data sets relating to a subject of interest; moving a second c-arm, positioned crosswise with respect to the first c-arm and supporting a second x-ray source and a second x-ray detector, about the first axis while obtaining a plurality of second x-ray attenuation data sets relating to the subject of interest; and synchronizing the movement of the first and second c-arms to avoid collision therebetween.. .
General Electric Company


08/27/15
20150238151 

System and perfusion-based arrhythmia alarm evaluation


A method of prioritizing arrhythmia alarms based on one patient's perfusion level includes receiving arterial blood pressure, electrocardiogram heart rate, and arterial pulse rate values of the one patient during a same time window. Analysing the set of blood pressure values to determine if an arrhythmia event is indicated, where if an arrhythmia event is indicated, the method includes calculating a systolic blood pressure (sbp) ratio, comparing the sbp ratio to a first predetermined threshold, and if the sbp ratio is less than or equal to the first predetermined threshold, then activating a non-perfusion alarm.
General Electric Company


08/27/15
20150238117 

Medical imaging accessory


A head restraint device for medical imaging apparatus, such as medical resonance imaging apparatus, is described. The device includes a base including a support for supporting the back of a subject's head.
Renishaw Plc


08/27/15
20150238035 

Garment clip


Provided is a garment clip for coupling to a garment hanger having a pair of pivotally connected opposing clip members and a curved loop with an aperture in which the garment hanger hook can be inserted. The curved loop provides a heart like shape having a pointed end.

08/27/15
20150238030 

Leakproof cover for combined pouring and venting container closure


A leakproof cover for combined pouring and venting container closure is disclosed which comprises a cap having an outer surface and an inner surface, a first arm having an aperture, a latch, a projection, a stop member extending downwardly from the inner surface, and a second arm extending downwardly from the inner surface with the second arm having an aperture, a closure device having a threaded rim, a vent, a spout; a pair of arms each having an aperture therein, a first pin for insertion through the apertures in the pair of arms and the aperture in the first arm of the cap for connecting the cap to the closure device, a spout seal device having a pair of arms each having an aperture, an upper member having a pair of depending legs with the upper member and the legs for covering the spout, the upper member having a rubber insert that provides a seal between the spout and the spout seal device to prevent any liquid from leaking out of the spout, and a second pin for insertion through the apertures in the pair of arms of the spout seal device and the aperture in the second arm for connecting the spout seal device to the cap.. .

08/27/15
20150238019 

Bed covering elevating system


A bed covering elevating system elevates bed sheets, blankets or the like over a person's feet to prevent pressure on the person's toes. The system includes a mattress.



Popular terms: [SEARCH]



Follow us on Twitter
twitter icon@FreshPatents

###

This listing is a sample listing of patent applications related to Arm for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Arm with additional patents listed. Browse our RSS directory or Search for other possible listings.


0.436

6697

0 - 1 - 118